Navigation Links
MacroGenics Appoints New Vice President of Business Development
Date:3/26/2009

ROCKVILLE, Md., March 26 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the appointment of Eric Risser as Vice President, Business Development. "I am very pleased that we have been able to attract another exceptionally talented professional to the management team at MacroGenics," said Dr. Scott Koenig, President and CEO. "Eric has spent the last 15 years focused on life sciences; his skills will complement our management team's expertise as we position our company for growth and advance our pipeline towards commercialization."

Mr. Risser brings a wealth of strategic and transactional experience. Prior to joining MacroGenics, he served as Senior Director, Business Development at Johnson & Johnson Pharmaceuticals, which he joined in 2003. While at Johnson & Johnson, he was responsible for leading global transactions in the pharmaceuticals area, including company acquisitions, product licenses and research collaborations. His areas of expertise include originating collaboration opportunities, managing multi-disciplinary project teams, structuring and negotiating transactions, and formulating integration and alliance management plans.

Before Johnson & Johnson, Mr. Risser started and built a successful consulting practice that provided counsel to emerging life science companies in the United States and Europe. He has also worked as a venture capitalist with BankAmerica Ventures as an investment banker with Lehman Brothers, where he began his career in their New York and London offices. Mr. Risser holds an M.B.A. from Stanford University and a B.A. from Yale University.

"Eric joins us at an important time in MacroGenics' growth as a company. His business development expertise and skill set will be especially important as we seek glob
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MacroGenics Raises $25M in Series D-2 Financing
2. MacroGenics Acquires Raven Biotechnologies
3. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
4. DOR BioPharma Appoints Gregg Lapointe, CPA, MBA, to its Board of Directors
5. DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
6. Veridiam Appoints Andrew Gale as Chief Executive Officer
7. Pharmaxis Appoints French Distributor for Aridol(TM)
8. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
9. PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors
10. China-Biotics, Inc. Appoints New Chief Financial Officer
11. Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Springs, FL (PRWEB) December 18, 2014 ... of the nation’s leading specialty pharmacies, has an ... serve as clinical pharmacy consultants for prescriber offices ... therapy expertise. , “We have a variety ... therapies. For example, those specializing in hepatitis C ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for Research and ... the Neurosciences (CEN), and professor of pharmacology at the ... member of the prestigious Dana Alliance for Brain Initiatives ... receive this honor. , The Dana Alliance ... Foundation. Its mission is to advance public education ...
(Date:12/19/2014)... 2014 In contrast to traditional LED ... various colors, Valoya uses proprietary LED technology to incorporate ... possible uniformity which is critical in low proximity installations. ... accuracy throughout its lifetime which is up to four ... , "The investment cost was clearly higher when compared ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3
... PAREXEL International,Corporation (Nasdaq: PRXL ), a leading ... is among the first to conduct a,Chinese bridging ... in providing,Asian bridging studies, which are conducted in ... global plans, gather,relevant ethnic data in the U.S., ...
... coupled with broader range of application areas are expected to drive ... fueled by heightened interest in biopharmaceutical therapeutics, human and veterinary vaccine ... ... San Jose, CA (PRWEB) November 6, 2008 -- Cell culture is ...
... Conference Call Scheduled for November 6, 2008 at 10:00 a.m. ... (Nasdaq: SVNT ) today reported financial results for,the three ... for the,third quarter of 2008 was $18.2 million or $0.34 ... compared with a net loss of $14.6,million or $0.28 per ...
Cached Biology Technology:PAREXEL Expands Pioneering Asian Ethnobridging Expertise 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 5Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts 2Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts 3Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 10
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ... technology is accurate, flexible and robust – with the ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... of the Journal of the American Dietetic Association ... dietary quality among children; and relationships between eating habits ... of Eating Disorders , While vegetarians tend to eat ... be overweight or obese, they may be at increased ...
... 2009 Joseph H. Holmes Pioneer Awards will be presented on ... New York. The awards honor two recipients who have contributed ... science award will be presented to Lawrence Platt, MD, of ... California in Los Angeles, California. The basic science award will ...
... MD, will present the William J. Fry Memorial Lecture ... the 2009 AIUM Annual Convention in New York, New ... an AIUM member that has significantly contributed to the ... field. Alred Kurtz, MD, currently serves as a ...
Cached Biology News:News from the April 2009 Journal of the American Dietetic Association 2AIUM Presents 2009 Joseph H. Holmes Pioneer Awards 2AIUM presents 2009 William J. Fry Memorial Lecture award 2
... Recognizes K+ Cl- Cotransporter-1 ... no significant sequence homology ... CCC.,SPECIES REACTIVITIES: The immunogen ... in human, mouse, porcine ...
...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
oligophrenin-1 (H-100)...
Biology Products: